Egypt Healthcare & Pharmaceuticals Industry Market Report
- The Trade Adviser
- Jun 20, 2024
- 1 min read
Updated: Jun 14
The healthcare and pharmaceuticals industry in Egypt is a critical component of the national economy, facilitating medical care, public health, and pharmaceutical production. As of 2023, the healthcare and pharmaceuticals sector is valued at approximately USD 12 billion, with hospitals, clinics, and pharmaceutical manufacturing being the primary components (source: Egyptian Ministry of Health and Population).
The sector has seen an annual growth rate of 10% over the past five years, driven by government initiatives, increasing healthcare demand, and technological advancements. Egypt's GDP stood at USD 403 billion in 2022, with the healthcare and pharmaceuticals sector accounting for about 3% of the total (source: World Bank). The future growth potential of the sector is substantial, with projections indicating that the market could reach USD 20 billion by 2030, supported by ongoing investments and healthcare reforms.
